Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2003-10-24
2008-10-28
Davis, Brian J (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C546S329000, C548S247000, C549S417000, C514S352000, C514S378000, C514S460000, C514S653000
Reexamination Certificate
active
07442839
ABSTRACT:
The present invention relates to novel compounds of formula (I),to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of respiratory diseases.
REFERENCES:
patent: 2918408 (1959-12-01), Biel
patent: 4778054 (1988-10-01), Newell et al.
patent: 4811731 (1989-03-01), Newell et al.
patent: 5035237 (1991-07-01), Newell et al.
patent: 5552438 (1996-09-01), Christensen, IV
patent: 5590645 (1997-01-01), Davies et al.
patent: 5860419 (1999-01-01), Davies et al.
patent: 5873360 (1999-02-01), Davies et al.
patent: 5998428 (1999-12-01), Barnette et al.
patent: 6321747 (2001-11-01), Dmitrovic et al.
patent: 35138885 (1985-10-01), None
patent: 3524990 (1986-01-01), None
patent: 162576 (1985-11-01), None
patent: 220054 (1987-04-01), None
patent: 0947498 (1999-10-01), None
patent: 2064336 (1981-06-01), None
patent: 2129691 (1984-05-01), None
patent: 2140800 (1984-12-01), None
patent: 2159151 (1985-11-01), None
patent: 2165542 (1986-04-01), None
patent: 2169265 (1986-07-01), None
patent: 2178965 (1987-02-01), None
patent: 2230523 (1990-10-01), None
patent: 2242134 (1991-09-01), None
patent: WO 98/29405 (1998-07-01), None
patent: WO 99/16766 (1999-04-01), None
patent: WO 99/47505 (1999-09-01), None
patent: WO 00/51599 (2000-09-01), None
patent: WO 01/13953 (2001-03-01), None
patent: WO 01/96278 (2001-12-01), None
patent: WO 02/066422 (2002-08-01), None
patent: WO 03/024439 (2003-03-01), None
patent: WO 2004/037807 (2004-05-01), None
Augstein et al., “Aryloxyalkylaminoguanidines. Their synthesis and biological properties,”J. Med. Chem10:391-400 (1967).
Connon et al., “Recent developments in olefin cross-metathesis,”Angew. Chem. Int. Ed. 42(17):1900-1923 (Apr. 2003).
Fuji et al., “Novel phosphodiesterase 4 inhibitor T-440 reverses and prevents human bronchial contraction induced by allergen,”The Journal of Pharmacology and Experimental Theapeutics284(1):162-169 (1998).
Hett et al., “Large-scale synthesis of enantio- and diastereomerically pure (R,R)-formoterol,”Organic Process Research&Development2(2):96-99 (Mar. 1998).
Kaiser et al., “Adrenergic agents. 4. Substituted phenoxypropanolamine derivatives as potential β-adrenergic agonists,”J. Med. Chem. 20(5):687-692 (May 1977).
Landells et al., “Oral administration of the phosphodiesterase (PED)4 inhibitor, V11294A inhibits ex-vivo agonist-induced cell activation,”Eur Resp J. 12 (Suppl. 28):Abst. P2393 CAS reference No. 162401-32-3 (Sep. 19-23, 1998).
LeClerc et al., “Synthesis and structure-activity relationships among α-adrenergic receptor agonists of the phenylethanolamine type,”J. Med. Chem. 23(7):738-744 (1980).
Sonesson et al., “An efficient synthesis of the novel dopamine autoreceptor antagonist S-(-)-OSU6162,viapalladium catalyzed cross-coupling reaction,”Tet. Letts. 35(48):9063-9066 (Nov. 1994).
Chapman Alan Michael
Guntrip Stephen Barry
Looker Brian Edgar
Procopiou Panayiotis Alexandrou
Davis Brian J
Glaxo Group Limited
Smith Robert J.
LandOfFree
Phenethanolamine derivative for the treatment of respiratory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenethanolamine derivative for the treatment of respiratory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenethanolamine derivative for the treatment of respiratory... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4006212